PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonary Medicine, Victoria Hospital, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. Electronic address: shashibhushanbl@yahoo.com.\', \'BAJ RR Hospital and Research Centre, Dombivali East, Maharashtra, India.\', \'BAPS Pramukh Swami Hospital, Surat, Gujarat, India.\', \'Sanjivani Super Speciality Hospital, Ahmedabad, Gujarat, India.\', \'PCMC\'s, PGI, Yashwantrao Chavan Memorial Hospital, Pune, Maharashtra, India.\', \'College of Medicine and Sagore Dutta Hospital, Kamahati, Kolkata, West Bengal, India.\', \'St. George\'s Hospital, Fort, Mumbai, Maharashtra, India.\', \'Joshi Clinic, Mumbai, Maharashtra, India.\', \'Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00677-910.1016/j.ijid.2021.08.044
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34428542
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all